These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

638 related items for PubMed ID: 15282457

  • 1. Can extra protamine eliminate heparin rebound following cardiopulmonary bypass surgery?
    Teoh KH, Young E, Blackall MH, Roberts RS, Hirsh J.
    J Thorac Cardiovasc Surg; 2004 Aug; 128(2):211-9. PubMed ID: 15282457
    [Abstract] [Full Text] [Related]

  • 2. Heparin binding proteins. Contribution to heparin rebound after cardiopulmonary bypass.
    Teoh KH, Young E, Bradley CA, Hirsh J.
    Circulation; 1993 Nov; 88(5 Pt 2):II420-5. PubMed ID: 8222188
    [Abstract] [Full Text] [Related]

  • 3. Heparin rebound phenomenon--much ado about nothing?
    Martin P, Horkay F, Gupta NK, Gebitekin C, Walker DR.
    Blood Coagul Fibrinolysis; 1992 Apr; 3(2):187-91. PubMed ID: 1606290
    [Abstract] [Full Text] [Related]

  • 4. Management of postoperative heparin rebound following cardiopulmonary bypass.
    Pifarré R, Babka R, Sullivan HJ, Montoya A, Bakhos M, El-Etr A.
    J Thorac Cardiovasc Surg; 1981 Mar; 81(3):378-81. PubMed ID: 7464201
    [Abstract] [Full Text] [Related]

  • 5. Heparin and protamine titration do not improve haemostasis in cardiac surgical patients.
    Shore-Lesserson L, Reich DL, DePerio M.
    Can J Anaesth; 1998 Jan; 45(1):10-8. PubMed ID: 9466020
    [Abstract] [Full Text] [Related]

  • 6. The role of the activated clotting time in heparin administration and neutralization for cardiopulmonary bypass.
    Esposito RA, Culliford AT, Colvin SB, Thomas SJ, Lackner H, Spencer FC.
    J Thorac Cardiovasc Surg; 1983 Feb; 85(2):174-85. PubMed ID: 6823136
    [Abstract] [Full Text] [Related]

  • 7. Anticoagulant monitoring and neutralization during open heart surgery--a rapid method for measuring heparin and calculating safe reduced protamine doses.
    Umlas J, Taff RH, Gauvin G, Swierk P.
    Anesth Analg; 1983 Dec; 62(12):1095-9. PubMed ID: 6650893
    [Abstract] [Full Text] [Related]

  • 8. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
    Mittermayr M, Velik-Salchner C, Stalzer B, Margreiter J, Klingler A, Streif W, Fries D, Innerhofer P.
    Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
    [Abstract] [Full Text] [Related]

  • 9. A pilot study indicating that bradykinin B2 receptor antagonism attenuates protamine-related hypotension after cardiopulmonary bypass.
    Pretorius M, Scholl FG, McFarlane JA, Murphey LJ, Brown NJ.
    Clin Pharmacol Ther; 2005 Nov; 78(5):477-85. PubMed ID: 16321614
    [Abstract] [Full Text] [Related]

  • 10. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery.
    Vonk AB, Veerhoek D, van den Brom CE, van Barneveld LJ, Boer C.
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):235-41. PubMed ID: 24342152
    [Abstract] [Full Text] [Related]

  • 11. Neutralization of enoxaparine-induced bleeding by protamine sulfate.
    Van Ryn-McKenna J, Cai L, Ofosu FA, Hirsh J, Buchanan MR.
    Thromb Haemost; 1990 Apr 12; 63(2):271-4. PubMed ID: 2163553
    [Abstract] [Full Text] [Related]

  • 12. Postoperative bleeding in cardiovascular surgery. Does heparin rebound really exist?
    Gundry SR, Drongowski RA, Klein MD, Coran AG.
    Am Surg; 1989 Mar 12; 55(3):162-5. PubMed ID: 2919841
    [Abstract] [Full Text] [Related]

  • 13. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W, Spannagl M, Boehm J, Hauner K, Braun S, Schuster T, Busley R.
    Anesth Analg; 2008 Nov 12; 107(5):1469-78. PubMed ID: 18931201
    [Abstract] [Full Text] [Related]

  • 14. Thrombin generation during cardiac surgery: is heparin the ideal anticoagulant?
    Brister SJ, Ofosu FA, Buchanan MR.
    Thromb Haemost; 1993 Aug 02; 70(2):259-62. PubMed ID: 8236131
    [Abstract] [Full Text] [Related]

  • 15. Protamine dosage based on two titrations reduces blood loss after valve replacement surgery: a prospective, double-blinded, randomized study.
    Guo Y, Tang J, Du L, Liu J, Liu RC, Liu X, Guo Y.
    Can J Cardiol; 2012 Aug 02; 28(5):547-52. PubMed ID: 22633184
    [Abstract] [Full Text] [Related]

  • 16. Subtle differences in commercial heparins can have serious consequences for cardiopulmonary bypass patients: A randomized controlled trial.
    Arsenault KA, Paikin JS, Hirsh J, Dale B, Whitlock RP, Teoh K, Young E, Ginsberg JS, Weitz JI, Eikelboom JW.
    J Thorac Cardiovasc Surg; 2012 Oct 02; 144(4):944-950.e3. PubMed ID: 22743176
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of a heparin removal device in comparison with protamine after hypothermic cardiopulmonary bypass.
    Tao W, Deyo DJ, Brunston RL, Vertrees RA, Grochoske TL, Zwischenberger JB.
    ASAIO J; 1997 Oct 02; 43(5):M825-30. PubMed ID: 9360162
    [Abstract] [Full Text] [Related]

  • 18. Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass.
    Andreasen JJ, Nielsen C.
    Eur J Cardiothorac Surg; 2004 Aug 02; 26(2):311-7. PubMed ID: 15296889
    [Abstract] [Full Text] [Related]

  • 19. Heparinase thromboelastography compared with activated coagulation time for protamine titration after cardiopulmonary bypass.
    Levin AI, Heine AM, Coetzee JF, Coetzee A.
    J Cardiothorac Vasc Anesth; 2014 Apr 02; 28(2):224-9. PubMed ID: 24461364
    [Abstract] [Full Text] [Related]

  • 20. A comparison of thromboelastography with heparinase or protamine sulfate added in vitro during heparinized cardiopulmonary bypass.
    Spiess BD, Wall MH, Gillies BS, Fitch JC, Soltow LO, Chandler WL.
    Thromb Haemost; 1997 Aug 02; 78(2):820-6. PubMed ID: 9268178
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.